Disciplined Investments’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2
Closed -$63 1612
2023
Q2
$63 Sell
2
-1
-33% -$34 ﹤0.01% 1646
2023
Q1
$109 Hold
3
﹤0.01% 1567
2022
Q4
$89 Buy
3
+1
+50% +$32 ﹤0.01% 1544
2022
Q3
$0 Sell
2
-1
-33% -$46 ﹤0.01% 1668
2022
Q2
$0 Buy
3
+1
+50% +$38 ﹤0.01% 1680
2022
Q1
$0 Buy
+2
New +$103 ﹤0.01% 1659

Other funds holding ASTH

Disciplined Investments's ASTH Position: Q3 2023 in Review

Disciplined Investments sold out of Astrana Health (ASTH) in Q3 2023, closing a stake of 2 shares — an estimated $63 sold.

Disciplined Investments first reported a position in ASTH in Q1 2022 and held it in 6 quarters. The position peaked at $109 in Q1 2023. 134 funds tracked by Wall St. Rank hold ASTH as of Q3 2023.

  • Disciplined Investments reported no remaining Astrana Health position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 2 Astrana Health shares in Q3 2023, an estimated $63.
  • Disciplined Investments first reported a position in Astrana Health in Q1 2022 and held it in 6 quarters.
  • Disciplined Investments's Astrana Health position peaked at $109 in Q1 2023.
  • 134 funds tracked by Wall St. Rank held Astrana Health as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.